MARKET

SENS

SENS

Senseonics
AMEX
0.4698
+0.0008
+0.17%
Pre Market: 0.4732 +0.0034 +0.72% 08:43 05/22 EDT
OPEN
0.4740
PREV CLOSE
0.4690
HIGH
0.4797
LOW
0.4611
VOLUME
5.32K
TURNOVER
0
52 WEEK HIGH
1.050
52 WEEK LOW
0.3838
MARKET CAP
249.41M
P/E (TTM)
-3.4697
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at SENS last week (0513-0517)?
Weekly Report · 2d ago
Stifel Nicolaus Keeps Their Buy Rating on Senseonics Holdings (SENS)
TipRanks · 05/14 11:06
SENS Stock Earnings: Senseonics Holdings Meets EPS, Beats Revenue for Q1 2024
Senseonics Holdings just reported results for the first quarter of 2024. Senseonics Holdings reported earnings per share of -3 cents. The company reported revenue of $ million. This was better than the analyst estimate for revenue of $  million.
Investorplace · 05/14 00:55
Senseonics Holdings, Inc. Quarterly Report for the Period Ended March 31, 2024
Press release · 05/14 00:17
Mercy to use Senseonics Eversense RPM to monitor diabetic patients
Healthcare Mercy to use Senseonics Eversense RPM to monitor diabetic patients. Shares of Senseonics (NYSE:SENS) were up 6% in post-market trading Monday. The company announced that its new eversense Remote Patient Monitoring system for diabetes management will be used across St. Louis-based Mercy's healthcare system.
Seeking Alpha · 05/13 21:16
Senseonics, Mercy Partner To Improve Diabetes Population Health Management
Mercy will roll the program out first in its St. Louis-area communities. Senseonics' Eversense CGM technology will be used across a health system. It is the first implementation of the technology in a major U.S. Hospital system. The program will be rolled out in five states by 2025.
Benzinga · 05/13 20:42
Senseonics Holdings Q1 2024 GAAP EPS $(0.03), Inline, Sales $5.047M Beat $4.605M Estimate
Senseonics Holdings reports quarterly sales of $ million which beat the analyst consensus estimate. The company reported quarterly losses of $1 per share which met the analyst estimate. Senseonics reported sales of million for the same period last year. The company also reported quarterly profits of $0.
Benzinga · 05/13 20:10
*Senseonics Holdings Sees 1H Rev $10M >SENS
Dow Jones · 05/13 20:07
More
About SENS
Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems, Eversense, Eversense XL, and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every five minutes to a mobile app on the user's smartphone. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device. Its CGM system continually and accurately measures a person's glucose levels for up to six months.

Webull offers Senseonics Holdings Inc stock information, including AMEX: SENS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SENS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SENS stock methods without spending real money on the virtual paper trading platform.